Viewing data from:

VALPROIC ACID

ANDA

VALPROIC ACID | A075379 | PHARMACEUTICAL ASSOCIATES INC

1 strength0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 1 NDC

Highest NADAC/Unit

$0.0333

per ml

Lowest NADAC/Unit

$0.0333

per ml

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
00121067585VALPROIC ACID 250 MG/5 ML SOLN	$0.0333	ML	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

VA Federal Supply Schedule

Government-negotiated contract prices | 4 NDCs (4 FSS)

Lowest Price

$18.56

Highest Price

$222.24

FSS NDCs

Big4 NDCs

Description	Price	Type	Vendor	Contract End
00121-4675-00VALPROIC ACID 250MG/5ML SOLN,ORAL	$123.54	FSS	Golden State Medical Supply, Inc.	06/14/2028
00121-4675-40VALPROIC ACID 250MG/5ML SOLN,ORAL	$77.86	FSS	Golden State Medical Supply, Inc.	06/14/2028
00121-0675-85VALPROIC ACID 250MG/5ML SOLN,ORAL	$18.56	FSS	Golden State Medical Supply, Inc.	06/14/2028
00121-1350-00VALPROIC ACID 250MG/5ML SOLN,ORAL	$222.24	FSS	Golden State Medical Supply, Inc.	06/14/2028

Source: VA Federal Supply Schedule (va.gov). Prices are government-negotiated contract prices.

API Supply Chain10 active DMFs11 inactive

9 active API suppliers hold Drug Master Files for this ingredient.

PCASVALPROIC ACID

DMF 56781985

KATWIJK CHEMIE BVVALPROIC ACID

DMF 64281986

THE NIPPON SYNTHETIC CHEMICAL INDUSTRY CO LTDVALPROIC ACID

DMF 73801988

SCI PHARMTECH INCVALPROIC ACID

DMF 165582003

ANJAN DRUG PRIVATE LTDVALPROIC ACID USP

DMF 200342006

SUN PHARMACEUTICAL INDUSTRIES LTDVALPROIC ACID USP

DMF 214102008

SUN PHARMACEUTICAL INDUSTRIES LTDVALPROIC ACID USP (PROCESS-II)

DMF 357442021

AREVA SYNTHETICS LLCVALPROIC ACID USP

DMF 421782025

HEBEI CHENGUANG TONGSHENG PHARMA CO LTDVALPROIC ACID

DMF 428132025

EMNAR PHARMA PRIVATE LTDVALPROIC ACID

DMF 437022026

DUPONT NUTRITION BIOSCIENCES APSInactiveVALPROIC ACID

DMF 30611977

SYNTEX USA INCInactiveVALPROIC ACID

DMF 32111978

YODOGAWA PHARMACEUTICAL CO LTDInactiveVALPROIC ACID

DMF 33221978

PROCOS SPAInactiveVALPROIC ACID

DMF 43801981

ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIVInactiveVALPROIC ACID

DMF 46571982

SIEGFRIED AGInactiveVALPROIC ACID & SODIUM VALPROATE

DMF 60151985

LIANYUNGANG PHARMACEUTICAL FACTORYInactiveVALPROIC ACID

DMF 96661992

SIEGFRIED CHEMICALS INCInactiveVALPROIC ACID

DMF 131611998

SIEGFRIED CHEMICALS INCInactiveVALPROIC ACID USP

DMF 146071999

SIGNA SA DE CVInactiveVALPROIC ACID USP

DMF 172242004

CALYX CHEMICALS AND PHARMACEUTICALS LTDInactiveVALPROIC ACID

DMF 219702008

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Approval Letters

1 letter from Drugs@FDA

Date	Submission	Document
Dec 15, 2000	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (1)

#001 — 250MG/5ML

0 patents0 exclusivities▴

SYRUP;ORAL | Approved: Dec 15, 2000

No patent or exclusivity listings for this strength.